The Chemours Company
CC
$14.62
-$0.3625-2.42%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.08% | -1.47% | -4.39% | -2.91% | -7.61% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.08% | -1.47% | -4.39% | -2.91% | -7.61% |
| Cost of Revenue | 2.34% | 0.68% | -2.35% | -1.16% | -3.83% |
| Gross Profit | -4.20% | -9.74% | -11.87% | -9.58% | -20.68% |
| SG&A Expenses | 9.17% | -1.69% | 2.94% | -14.52% | -10.90% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.04% | 0.37% | -1.72% | -2.70% | -4.68% |
| Operating Income | -21.93% | -20.54% | -27.95% | -5.18% | -32.14% |
| Income Before Tax | -439.76% | 111.46% | 137.34% | 112.66% | 376.67% |
| Income Tax Expenses | 607.41% | 129.03% | 148.15% | -- | -146.55% |
| Earnings from Continuing Operations | -480.91% | 106.44% | 133.62% | 122.47% | 225.00% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 50.00% | -- | -- | -- | -- |
| Net Income | -488.89% | 106.40% | 133.33% | 121.84% | 222.73% |
| EBIT | -21.93% | -20.54% | -27.95% | -5.18% | -32.14% |
| EBITDA | -10.92% | -12.07% | -19.33% | -4.47% | -22.90% |
| EPS Basic | -486.42% | 106.41% | 133.36% | 121.88% | 211.20% |
| Normalized Basic EPS | -44.80% | -41.09% | -47.97% | -25.12% | -58.41% |
| EPS Diluted | -501.39% | 105.42% | 131.64% | 120.66% | 201.67% |
| Normalized Diluted EPS | -44.45% | -40.98% | -47.76% | -24.63% | -58.15% |
| Average Basic Shares Outstanding | 0.63% | 0.54% | 0.40% | 0.05% | -1.25% |
| Average Diluted Shares Outstanding | 0.08% | 0.23% | 0.06% | -0.29% | -1.46% |
| Dividend Per Share | -16.25% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | -1.22% | 16.51% | 3.98% | 5.58% | 1.80% |